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Murine Sarcoma Virus-induced Cytopathological Effects in
Mouse Cells made Resistant to 6-Azauridine (Accepted I I January 1974) SUMMARY Mouse cells made resistant to 6-azauridine were found to undergo syncytium formation upon infection with the Rauscher pseudotype of Moloney sarcoma virus (M-MSV(RLV)) and the Moloney strain of murine sarcoma virus (M-MSV(MLV)). The formation of syncytia was related to sarcoma virus replication since syncytia were never produced by leukaemia virus alone or by fl-propiolactone-inactivated M-MSV(RLV).
Cells with specific enzyme deficiencies manifested by resistance to otherwise lethal metabolites are useful in a variety of studies, including attempts to demonstrate virus genes coding for specific enzymes. For example, mouse ceils deficient in thymidine kinase can be induced to synthesize this enzyme by infection with herpes simplex virus (Kit & Dubbs, 1963) . We have initiated a survey of drug-resistant mouse cells with specific enzyme deficiencies for their ability to support the multiplication of leukaemia and sarcoma viruses. We may thus identify the virus gene products or host factors necessary for virus replication. In the course of these studies, several clones of mouse 3T6 cells (Todaro & Green, I963 ) rendered resistant to 6-azauridine (6-AU), were found to undergo syncytia formation after infection with murine sarcoma viruses, but not after infection with non-transforming type C murine viruses. The formation of syncytia appeared to depend on virus replication, and was as sensitive in assay as conventional sarcoma virus assays based on foci of cell transformation.
Two sarcoma virus strains, the Rauscher pseudotype of the Moloney strain M-MSV(RLV) and M-MSV(MLV), and three leukaemia virus strains, Rauscher (RLV), Friend (FLV), and Moloney (MLV), were used to infect secondary Swiss mouse embryo (ME) cells (MEC), random bred Swiss mouse embryo 3T6 cells, and three clonal derivatives of 3T6 cells made resistant to 6-AU. Cells were grown in Eagle's minimal essential medium (MEM) supplemented with Io % heat-inactivated foetal bovine serum in a Io % CO2 atmosphere at 37 °C. For focus assays, cells were grown in 5 % heated foetal bovine serum. All stock viruses were grown in NIH 3T 3 cells prior to the experiments described here, with no indication of cytopathological effects, other than the usual transformation associated with the sarcoma viruses. Virus infectivities were determined by the XC pIaque technique (Rowe, Pugh & Hartley, I97O) , the induction of reverse transcriptase (Kelloff, Hatanaka & Gilden, ~97z) , the induction of MuLV gs antigen (Hartley et al. I965) , or by focal transformation assays (Hartley & Rowe, I966) . Resistance to 6-AU was initiated by serial passage in the presence of 5 #g/ml of drug. After several months of passage, three clones were isolated that grew at 5oo/zg/ml. Subsequently, each clone was made resistant to 2ooo #g/ml of the drug. The clones were assayed for uridine kinase activity (Vesely et al. I97I ) and found to possess less than IO % of that of the 3T6 cells. Drug resistant cells were maintained in the presence of 2ooo/zg/ml of 6-AU until two days before infection with virus.
When IO ~ to io 4 infectious units of the various leukaemia viruses were added to the three different mouse cells, no morphological changes were observed during observation for I86 Short communications 2 to 3 weeks. Assays of reverse transcriptase and XC plaques were positive within one week of infection. Thus, the leukaemia viruses replicated normally in the 6-AU resistant 3T6 cells. In contrast, M-MSV(RLV) repeatedly induced syncytia ( Fig. ~) and ultimately cell death in 6-AU resistant cells, but only foci of transformation and XC plaques in the normal mouse cells (Table I) . Infectivity titrations based upon the end-point dilution for syncytia formation showed approx. Io-fold higher infectivities for the resistant cells than did the assay of transformed foci on 3T6 cells. Initially, typical foci were produced on 6-AU resistant ceils early in infection but these focal areas rapidly developed syncytia and their enumeration on the resistant cells became difficult. These initial results were repeatable but could not be attributed specifically to the sarcoma virus because of the possibilities of contamination with a syncytial virus. Such contamine.tion of cultures is unlikely for several reasons: (I) cultures with numerous syncytia were negative in haemadsorption tests with guinea pig red blood cells; (2) electron microscopic examination revealed only type C particles; (3) syncytia formation by M-MSV(RLV) on 6-AU resistant cells was inhibited by antiserum to RLV in exact parallel to the inhibition of reverse transcriptase and the induction of gs antigen (Table 2) * 6-AU (clone I) resistant cells were plated at 3 × Io ~ cells per 60 mm ~ Petri dish. The M-MSV(RLV) stock virus was diluted 1:5o in serum-free medium (SFM) and mixed with an equal vol. of dilutions of rabbit anti-KiMSV(KiMuLV) and incubated for 3o min at 36 °C. The 6-AU resistant cells were then infected with the mixture for I h when cells were washed with SFM and complete media added back. This antiserum gave > 9o % reduction of RLV infectivity when used undiluted, and 5o % reduction when used at dilutions of 1[8o and I/i6o. This was consistent in repeated tests over a period of 4 years.
t Acid insoluble ct/min determined at 7 days post-infection using [3H]-TTP as substrate and poly rA : oligo dT12_x8 as template-primer. The background activity in uninfected cultures was I5o to 2o0 ct]min.
:~ Discrete areas containing at least 3 nuclei per giant cell determined at 8 days post-infection. § Leukaemia virus was determined by overlaying with XC cells 7 days post-infection and counting the plaques 3 days later.
II Complement fixation tests on 2o % cell suspensions at I4 days post-infection using specific anti-MuLV gs antisera. Negative -reaction undiluted; positive ~-at maximum reaction at 1:4 dilution in test.
only typical transformed foci.on MEC and 3T6 cells with no indication of syncytia (Table 3) . When these yields from MEC or 3T6 cells were replated on 6-AU resistant cells, syncytia were formed again with about ~o-fold higher infectivities than those indicated by focus formation on MEC. Similar experiments using M-MSV (RLV) passaged on normal 3T6 cells and transferred to MEC, failed to show syncytia. These results indicated strongly that the syncytia obtained on 6-AU resistant cells were the result of replication of sarcoma virus.
To rule out virus-cell membrane interactions not involving replication, concentrated and purified preparations of RLV and New Zealand Black mouse (NZB) viruses from bands in I88 Short communications * 6-AU-3T6 (clone I) cells were infected with dilutions of M-MSV(RLV) and assayed after I week as described in Table I. I ml of media from each dilution of the 6-AU-3T6 titration was used to infect MEC. Results shown were obtained i week later.
1 ml of media from each dilution of the MEC titration was replated on 6-AU-3T6 cells and assays performed 1 week later.
§ TNTC, too numerous to count.
sucrose gradients were diluted serially and plated directly on confluent monolayers of 6-AU resistant cells and XC cells. The monolayers of XC cells developed syncytia within 3 days and gave endpoint dilutions of I : 2560 for RLV and I : ~28o for NZB virus. The 6-AU resistant cells showed no syncytia at any dilution even after one week. in addition, a MSV(RLV) virus preparation was inactivated by incubation overnight at 4 °C with o.o6r % p-propiolactone (BPL). Both this and a control preparation without BPL were then concentrated 3o-fold by sedimentation. Complete transformation of 6-AU cells, including formation of syncytia, occurred at dilutions up to I "32 within 5 days in the untreated virus control. The 6-AU cells receiving the BPL treated MSV(RLV) developed no foci of transformation or syncytia within 3 weeks of observation. The co-cultivation of 6-AU resistant cells with a 3T3/B nonproducer cell carrying the defective sarcoma virus genome resulted in no syncytia formation during observation for one week. These results also imply a role for sarcoma virus replication in syncytia formation. The induction of syncytia by murine type C viruses in mixed culture assays has been described (Klement et al. 1969) . More recently, the RD-r I4 virus has been shown to produce syncytia directly in KB, KC, and human lymphoid cells (Klement & McAllister, I972; Rand & Long, I972; Hampar et al. I973) ; however, we are unaware of examples of syncytia formation limited exclusively to sarcoma viruses. We are hopeful that further analyses of the responses of 6-AU resistant cells may reveal a sarcoma virus-specific function or a host cell function involved-in the replication of sarcoma virus. The analysis of 6-AU resistant cells derived independently of those described here, or of revertants sensitive to 6-AU, is necessary before we can conclude that the resistance to 6-AU or the low levels of uridine kinase are related to our present results.
